Success Metrics

Clinical Success Rate
88.9%

Based on 16 completed trials

Completion Rate
89%(16/18)
Active Trials
3(9%)
Results Posted
0%(0 trials)
Terminated
2(6%)

Phase Distribution

Ph phase_2
3
9%
Ph not_applicable
10
31%
Ph phase_3
4
13%
Ph phase_4
4
13%

Phase Distribution

0

Early Stage

3

Mid Stage

8

Late Stage

Phase Distribution21 total trials
Phase 2Efficacy & side effects
3(14.3%)
Phase 3Large-scale testing
4(19.0%)
Phase 4Post-market surveillance
4(19.0%)
N/ANon-phased studies
10(47.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

16 of 18 finished

Non-Completion Rate

11.1%

2 ended early

Currently Active

3

trials recruiting

Total Trials

32

all time

Status Distribution
Active(3)
Completed(16)
Terminated(2)
Other(11)

Detailed Status

Completed16
unknown11
Recruiting3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
32
Active
3
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (14.3%)
Phase 34 (19.0%)
Phase 44 (19.0%)
N/A10 (47.6%)

Trials by Status

recruiting39%
completed1650%
terminated26%
unknown1134%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT05770349

Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure

Recruiting
NCT07373678

CABG Versus PCI in Patients With Isolated LAD Chronic Total Occlusion

Completed
NCT07362108

Cardiovascular Events Related to Treated Coronary Arteries in Stable Multivessel CAD

Completed
NCT06399705Phase 3

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

Recruiting
NCT05143671

Prospective Evaluation for Hybrid Cardiac Procedures

Completed
NCT06749171

Coronary Revascularization Outcomes Within Necessary Sex and Gender Aspects

Completed
NCT06614023

Impact of Body Weight on Outcomes of Patients Undergoing Coronary Artery Bypass Grafting

Completed
NCT06215300

The Effect of Polymorphism of the GUCY1A3 rs7692387 Gene on Cardiovascular Events After Coronary Artery Bypass Grafting.

Unknown
NCT04698460Not Applicable

FUNctional eFficacy of Hybrid coronAry REvascularization

Terminated
NCT05532631Not Applicable

Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With Left Ventricular Dysfunction (PROVERB)

Recruiting
NCT04916912

Results of Coronary Artery Bypass Grafting in Obese Patients

Completed
NCT00475488Not Applicable

Radial Artery Patency and Clinical Outcomes Trial

Unknown
NCT04041921

Chronic Total Occlusion Registry

Terminated
NCT04639856Not Applicable

ICU Stay in Patients With Low Ejection Fraction Undergoing Cardiac Revascularization: Comparison of On-pump vs Off-pump Coronary Artery Bypass Grafting

Completed
NCT03774342

The Influence of Cognitive Decline on Quality of Life After Coronary Bypass

Unknown
NCT03539354Not Applicable

TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery

Unknown
NCT02984371Phase 2

Epicardial Fat Pads Ablation During Coronary Surgery

Unknown
NCT02982434Phase 2

The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation

Unknown
NCT02894255Phase 4

Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents

Unknown
NCT02775578Not Applicable

Optimizing Strategy of Coronary Revascularization in Patients With Multivessel Lesions Combined Heart Failure

Unknown

Drug Details

Intervention Type
PROCEDURE
Total Trials
32